7Baggers
Quarterly
Annual
    Unit: USD2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-06-30 2015-03-31 2014-12-31 
                   
      operating activities
    		               
      net income
    		1,537,000,000 1,623,000,000 1,489,000,000 1,595,000,000 1,423,000,000 1,169,000,000 1,307,000,000 1,361,000,000 851,000,000 877,000,000 795,000,000 647,000,000 791,000,000 860,000,000 806,000,000 
      adjustments to reconcile net income to net cash from operating activities:
    		               
      depreciation and amortization
    		108,000,000 111,000,000 111,000,000 108,000,000 102,000,000 106,000,000 110,000,000 109,000,000 58,000,000 57,000,000 58,000,000 56,000,000 65,000,000 63,000,000 63,000,000 
      noncash lease expense
    		32,000,000 32,000,000 32,000,000 31,000,000 34,000,000 43,000,000 42,000,000 41,000,000        
      stock-based compensation
    		179,000,000 176,000,000 161,000,000 146,000,000 158,000,000 165,000,000 172,000,000 160,000,000 113,000,000 119,000,000 117,000,000 172,000,000 126,000,000 143,000,000 117,000,000 
      deferred income tax expense
    		-39,000,000 -41,000,000 83,000,000 -17,000,000 5,000,000 53,000,000 706,000,000 -116,000,000 -8,000,000 -61,000,000 -43,000,000 98,000,000  87,000,000 -73,000,000 
      other investment
    		               
      net losses within cips
    		-66,000,000 -104,000,000 -264,000,000 51,000,000            
      net (purchases) proceeds within cips
    		-463,000,000 -989,000,000 -393,000,000 -440,000,000 -470,000,000 -477,000,000 -386,000,000 -214,000,000        
      losses from equity method investees
    		-44,000,000 -48,000,000 -74,000,000 -113,000,000            
      distributions of earnings from equity method investees
    		18,000,000 8,000,000 17,000,000 14,000,000 10,000,000 8,000,000 23,000,000 -5,000,000 15,000,000 4,000,000 2,000,000 10,000,000 16,000,000 9,000,000 13,000,000 
      changes in operating assets and liabilities:
    		               
      accounts receivable
    		-27,000,000 -73,000,000 21,000,000 -135,000,000 -202,000,000 -270,000,000 162,000,000 38,000,000 250,000,000 288,000,000 -354,000,000 -270,000,000 497,000,000 -750,000,000 504,000,000 
      investments, trading
    		-31,000,000 -9,000,000 20,000,000 40,000,000 10,000,000 2,000,000 -21,000,000 102,000,000 -171,000,000 -56,000,000 -137,000,000 -85,000,000 -89,000,000 -336,000,000 -227,000,000 
      other assets
    		-268,000,000 -796,000,000 1,084,000,000 927,000,000 -1,641,000,000 -696,000,000 2,107,000,000 -1,049,000,000 -16,000,000 43,000,000 -99,000,000 -58,000,000 -200,000,000 -91,000,000 138,000,000 
      accrued compensation and benefits
    		391,000,000 -1,339,000,000 624,000,000 396,000,000 368,000,000 -1,243,000,000 571,000,000 300,000,000 398,000,000 419,000,000 393,000,000 -1,296,000,000 456,000,000 -1,188,000,000 373,000,000 
      accounts payable and accrued liabilities
    		-100,000,000 196,000,000 41,000,000 43,000,000 -19,000,000 -91,000,000 -274,000,000 241,000,000 -258,000,000 -256,000,000 239,000,000 326,000,000 -421,000,000 654,000,000 -542,000,000 
      other liabilities
    		173,000,000 869,000,000 -957,000,000 -1,070,000,000 1,437,000,000 965,000,000 -2,364,000,000 949,000,000 -70,000,000 -4,000,000 -225,000,000 246,000,000 13,000,000 90,000,000 -23,000,000 
      net cash from operating activities
    		1,365,000,000 -408,000,000 1,998,000,000 1,576,000,000            
      capital expenditures
    		-7,000,000 -64,000,000 -124,000,000 -78,000,000            
      free cash flows
    		1,358,000,000 -472,000,000 1,874,000,000 1,498,000,000            
      investing activities
    		               
      purchases of investments
    		-193,000,000 -324,000,000 -165,000,000 -97,000,000 -266,000,000 -318,000,000 -308,000,000 -133,000,000 -85,000,000 -223,000,000 -14,000,000 -55,000,000 -61,000,000 -101,000,000 -65,000,000 
      proceeds from sales and maturities of investments
    		310,000,000 210,000,000 130,000,000 91,000,000 37,000,000 142,000,000 52,000,000 73,000,000 163,000,000 18,000,000 64,000,000 133,000,000 162,000,000 152,000,000 150,000,000 
      distributions of capital from equity method investees
    		155,000,000 162,000,000 20,000,000 9,000,000 9,000,000 8,000,000 11,000,000 25,000,000 8,000,000 11,000,000 9,000,000 6,000,000 37,000,000 9,000,000 13,000,000 
      net consolidations (deconsolidations) of sponsored investment funds
    		-28,000,000 -6,000,000 -47,000,000 -6,000,000 0 27,000,000 -37,000,000 -43,000,000 0 -54,000,000 -12,000,000 -8,000,000 -108,000,000 27,000,000 -90,000,000 
      acquisition, net of cash acquired
    		               
      purchases of property and equipment
    		-7,000,000 -64,000,000 -124,000,000 -78,000,000 -61,000,000 -81,000,000 -134,000,000 -136,000,000 -31,000,000 -21,000,000 -37,000,000 -30,000,000 -36,000,000 -98,000,000 -26,000,000 
      net cash from investing activities
    		163,000,000 -22,000,000 -186,000,000 -270,000,000            
      financing activities
    		               
      repayments of long-term borrowings
    		0 -1,000,000,000     0 0        
      proceeds from long-term borrowings
    		0 2,979,000,000 0 0           0 
      cash dividends paid
    		-758,000,000 -795,000,000 -743,000,000 -748,000,000 -748,000,000 -796,000,000 -731,000,000 -736,000,000 -374,000,000 -376,000,000 -376,000,000 -419,000,000 -364,000,000 -389,000,000 -322,000,000 
      proceeds from stock options exercised
    		19,000,000 144,000,000 44,000,000 24,000,000 0 27,000,000   0       
      repurchases of common stock
    		-519,000,000 -634,000,000 -384,000,000 -396,000,000 -383,000,000 -721,000,000 -505,000,000 -384,000,000 -281,000,000 -277,000,000 -279,000,000 -562,000,000 -279,000,000 -498,000,000 -256,000,000 
      net proceeds from (repayments of) borrowings by cips
    		86,000,000 -14,000,000 -21,000,000 -15,000,000 -4,000,000 -19,000,000          
      net subscriptions received/(redemptions/distributions paid) from noncontrolling interest holders
    		525,000,000 430,000,000  392,000,000 335,000,000 305,000,000          
      other financing activities
    		6,000,000 -15,000,000 6,000,000 8,000,000 2,000,000 10,000,000 8,000,000 2,000,000 2,000,000 -7,000,000 7,000,000 3,000,000 -1,000,000 7,000,000 1,000,000 
      net cash from financing activities
    		-641,000,000 1,095,000,000 -503,000,000 -735,000,000            
      effect of exchange rate changes on cash, cash equivalents and restricted cash
    		-33,000,000 -27,000,000 111,000,000 -89,000,000 46,000,000 38,000,000 188,000,000 -186,000,000        
      net increase in cash, cash equivalents and restricted cash
    		854,000,000 638,000,000 1,420,000,000 482,000,000            
      cash, cash equivalents and restricted cash, beginning of period
    		0 8,753,000,000  0 0 7,433,000,000  0        
      cash, cash equivalents and restricted cash, end of period
    		854,000,000 9,391,000,000  482,000,000 1,190,000,000 5,661,000,000  316,000,000        
      supplemental schedule of noncash investing and financing transactions:
    		               
      issuance of common stock
    		25,000,000 392,000,000 15,000,000 30,000,000 14,000,000 510,000,000 9,000,000 20,000,000 13,000,000 24,000,000 14,000,000 616,000,000 12,000,000 458,000,000 14,000,000 
      increase in noncontrolling interests due to net consolidation (deconsolidation) of sponsored investment funds
    		-450,000,000 -353,000,000 -820,000,000 -67,000,000 -57,000,000 -5,000,000  -290,000,000 -558,000,000 -187,000,000 -394,000,000 -300,000,000 -57,000,000 18,000,000 -15,000,000 
      other investment gains
    		 -24,000,000     8,000,000         
      contingent consideration fair value adjustments
    		               
      acquisitions, net of cash acquired
    		               
      net (redemptions/distributions paid)/subscriptions received from noncontrolling interest holders
    		        147,000,000 255,000,000 383,000,000 361,000,000    
      cash, cash equivalents and restricted cash, beginning of year
    		               
      cash, cash equivalents and restricted cash, end of year
    		               
      supplemental disclosure of cash flow information:
    		               
      cash paid for:
    		               
      interest
    		        54,000,000 40,000,000 64,000,000 40,000,000 59,000,000 40,000,000 76,000,000 
      income taxes
    		        455,000,000 271,000,000 532,000,000 107,000,000 575,000,000 133,000,000 235,000,000 
      adjustments to reconcile net income to net cash provided by/(used in) operating activities:
    		               
      net (gains) losses within cips
    		     -88,000,000 -110,000,000 122,000,000        
      (earnings) losses from equity method investees
    		     -40,000,000 -83,000,000 -3,000,000 -42,000,000 -35,000,000 -33,000,000 -3,000,000 -18,000,000 -33,000,000 -25,000,000 
      net cash provided by/(used in) operating activities
    		     -394,000,000 1,973,000,000 1,760,000,000        
      net cash provided by/(used in) investing activities
    		     -222,000,000 -416,000,000 -214,000,000        
      net cash provided by/(used in) financing activities
    		     -1,194,000,000 -1,126,000,000 -1,044,000,000        
      net increase/(decrease) in cash, cash equivalents and restricted cash
    		     -1,772,000,000 619,000,000 316,000,000        
      charitable contribution
    		               
      gain related to the charitable contribution
    		               
      charitable contribution of an investment
    		               
      increase/(decrease) in noncontrolling interests due to net consolidation (deconsolidation) of sponsored investment funds
    		               
      net contributions (redemptions/distributions) - noncontrolling interest holders
    		       74,000,000        
      cash flows from operating activities
    		        1,192,000,000 1,060,000,000 467,000,000 -565,000,000 986,000,000 -490,000,000 1,271,000,000 
      adjustments to reconcile net income to cash flows from operating activities:
    		               
      amortization of deferred sales commissions
    		        7,000,000 8,000,000 9,000,000 10,000,000 12,000,000 13,000,000 13,000,000 
      other gains
    		            0 -40,000,000  
      net (gains) losses on nontrading investments
    		          -2,000,000 3,000,000 -13,000,000 19,000,000 16,000,000 
      purchases of investments within consolidated sponsored investment funds
    		            4,000,000 -5,000,000 -9,000,000 
      proceeds from sales and maturities of investments within consolidated sponsored investment funds
    		            -17,000,000 18,000,000 24,000,000 
      assets and liabilities of consolidated vies:
    		               
      change in cash and cash equivalents
    		        8,000,000 -2,000,000 -79,000,000 -46,000,000 -223,000,000 209,000,000 158,000,000 
      net (gains) losses within consolidated vies
    		        18,000,000 -19,000,000 -13,000,000 -2,000,000 19,000,000 -35,000,000 6,000,000 
      net (purchases) proceeds within consolidated vies
    		        39,000,000 -321,000,000 -161,000,000 -373,000,000 55,000,000 -177,000,000  
      other adjustments
    		              -2,000,000 
      cash flows from investing activities
    		        55,000,000 -269,000,000 -20,000,000 46,000,000 -6,000,000 -99,000,000 -18,000,000 
      cash flows from financing activities
    		        -505,000,000 -370,000,000 -263,000,000 -547,000,000 -443,000,000 -748,000,000 -1,592,000,000 
      net proceeds from (repayments of) borrowings by consolidated vies
    		             -29,000,000 -24,000,000 
      excess tax benefit from stock-based compensation
    		        1,000,000 9,000,000 2,000,000 70,000,000 12,000,000 55,000,000 13,000,000 
      effect of exchange rate changes on cash and cash equivalents
    		        -105,000,000 -32,000,000 -100,000,000 -36,000,000 77,000,000 -93,000,000 -87,000,000 
      net increase in cash and cash equivalents
    		        637,000,000 389,000,000 84,000,000 -1,102,000,000 614,000,000 -1,430,000,000 -426,000,000 
      cash and cash equivalents, beginning of year
    		               
      cash and cash equivalents, end of year
    		               
      interest on borrowings of consolidated vies
    		             30,000,000 30,000,000 
      pnc preferred stock capital contribution
    		        0 0 0 172,000,000    
      increase in borrowings due to consolidation/deconsolidation of vies
    		               
      acquisitions
    		         0      
      cash and cash equivalents, beginning of period
    		         0 0 6,083,000,000 0 5,723,000,000  
      cash and cash equivalents, end of period
    		         389,000,000 84,000,000 4,981,000,000 614,000,000 4,293,000,000  
      gain related to pennymac initial public offering
    		               
      repayments of short-term borrowings
    		               
      acquisition
    		            0 -88,000,000  
      net (redemptions/distributions paid) / subscriptions received from noncontrolling interests holders
    		            123,000,000 106,000,000  
      increase in borrowings due to deconsolidation of vies
    		               
      increase in borrowings due to consolidation of vies
    		             603,000,000  
      net (purchases) proceeds and distributions within consolidated vies
    		               
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.